{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:24:39Z","timestamp":1765959879046},"reference-count":31,"publisher":"Impact Journals, LLC","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,5,16]]},"DOI":"10.18632\/oncotarget.16497","type":"journal-article","created":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T07:33:46Z","timestamp":1490254426000},"page":"33365-33374","source":"Crossref","is-referenced-by-count":12,"title":["Expression of EMT markers and mode of surgery are prognostic in phyllodes tumors of the breast"],"prefix":"10.18632","volume":"8","author":[{"given":"Xiaolong","family":"Feng","sequence":"first","affiliation":[{"name":"Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honghong","family":"Shen","sequence":"additional","affiliation":[{"name":"Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaozhen","family":"Liu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhua","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tianjin Union Medical Center, Tianjin People's Hospital, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Niu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,3,23]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.ijrobp.2007.06.059","article-title":"Phyllodes tumor of the breast","volume":"70","author":"Kadish","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1093\/jjco\/hyu177","article-title":"Comparison of the clinical and prognostic features of primary breast sarcomas and malignant phyllodes tumor","volume":"45","author":"Tong","year":"2015","journal-title":"Jpn J Clin Oncol"},{"key":"3","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1177\/1066896915592018","article-title":"Phyllodes Tumor of the Breast With Malignant Melanoma Component: A Case Report","volume":"23","author":"Taylor","year":"2015","journal-title":"Int J Surg Pathol"},{"key":"4","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/gcc.22256","article-title":"Distribution of MED12 mutations in fibroadenomas and phyllodes tumors of the breast--implications for tumor biology and pathological diagnosis","volume":"54","author":"Stenzinger","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"5","first-page":"162","article-title":"Cystosarcoma phyllodes of the breast","volume":"75","author":"Aletras","year":"1990","journal-title":"Int Surg"},{"key":"6","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s10549-014-3214-1","article-title":"C-kit overexpression correlates with KIT gene copy numbers increases in phyllodes tumors of the breast","volume":"149","author":"Niu","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"7","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00268-015-3262-7","article-title":"Treatment of Patients with Distant Metastases from Phyllodes Tumor of the Breast","volume":"40","author":"Kulpa","year":"2016","journal-title":"World J Surg"},{"key":"8","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Weinberg","year":"2009","journal-title":"J Clin Invest"},{"key":"9","doi-asserted-by":"publisher","first-page":"25320","DOI":"10.18632\/oncotarget.4659","article-title":"Epithelial derived CTGF promotes breast tumor progression via inducing EMT and collagen I fibers deposition","volume":"6","author":"Wong","year":"2015","journal-title":"Oncotarget"},{"key":"10","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1158\/0008-5472.CAN-14-3485","article-title":"Silencing beta3 Integrin by Targeted ECO\/siRNA Nanoparticles Inhibits EMT and Metastasis of Triple-Negative Breast Cancer","volume":"75","author":"Lu","year":"2015","journal-title":"Cancer Res"},{"key":"11","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/onc.2015.133","article-title":"TGF-beta1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7\/CCL21-mediated chemotaxis","volume":"35","author":"Sund","year":"2015","journal-title":"Oncogene"},{"key":"12","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10549-016-3713-3","article-title":"Erratum to: CXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis","volume":"155","author":"Bhattacharyya","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.biopha.2016.02.044","article-title":"The mechanism between epithelial mesenchymal transition in breast cancer and hypoxia microenvironment","volume":"80","author":"Li","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"14","doi-asserted-by":"publisher","first-page":"24677","DOI":"10.18632\/oncotarget.8250","article-title":"Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer","volume":"7","author":"Kim","year":"2016","journal-title":"Oncotarget"},{"key":"15","doi-asserted-by":"publisher","first-page":"51408","DOI":"10.18632\/oncotarget.9839","article-title":"Novel cancer stem cell targets during epithelial to mesenchymal transition in PTEN-deficient trastuzumab-resistant breast cancer","volume":"7","author":"Wicha","year":"2016","journal-title":"Oncotarget"},{"key":"16","doi-asserted-by":"publisher","first-page":"293","DOI":"10.18632\/oncotarget.6344","article-title":"miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer","volume":"7","author":"Fu","year":"2016","journal-title":"Oncotarget"},{"key":"17","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1007\/s13277-015-3709-3","article-title":"S100A4 participates in epithelial-mesenchymal transition in breast cancer via targeting MMP2","volume":"37","author":"Fan","year":"2016","journal-title":"Tumour Biol"},{"key":"18","doi-asserted-by":"publisher","first-page":"24537","DOI":"10.18632\/oncotarget.8233","article-title":"MiR-206 suppresses epithelial mesenchymal transition by targeting TGF-beta signaling in estrogen receptor positive breast cancer cells","volume":"7","author":"Lu","year":"2016","journal-title":"Oncotarget"},{"key":"19","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/bcr3631","article-title":"Malignant phyllodes tumors display mesenchymal stem cell features and aldehyde dehydrogenase\/disialoganglioside identify their tumor stem cells","volume":"16","author":"Yu","year":"2014","journal-title":"Breast Cancer Res"},{"key":"20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.humpath.2016.04.007","article-title":"Insulinlike growth factor II messenger RNA-binding protein-3 is an indicator of malignant phyllodes tumor of the breast","volume":"55","author":"Oda","year":"2016","journal-title":"Human Pathology"},{"key":"21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF02133961","article-title":"Cystosarcoma phyllodes: epidemiology, pathohistology, pathobiology, diagnosis, therapy, and survival","volume":"236","author":"Key","year":"1985","journal-title":"Arch Gynecol"},{"key":"22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10549-015-3296-4","article-title":"Prognostic significance of epithelial-mesenchymal transition proteins Twist and Foxc2 in phyllodes tumours of the breast","volume":"150","author":"Tan","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"23","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s13277-011-0296-9","article-title":"Molecules involved in epithelial-mesenchymal transition and epithelial-stromal interaction in phyllodes tumors: implications for histologic grade and prognosis","volume":"33","author":"Koo","year":"2012","journal-title":"Tumour Biol"},{"key":"24","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.2147\/OTT.S102422","article-title":"Paeoniflorin prevents hypoxia-induced epithelial-mesenchymal transition in human breast cancer cells","volume":"9","author":"Hu","year":"2016","journal-title":"Onco Targets Ther"},{"key":"25","doi-asserted-by":"publisher","first-page":"896","DOI":"10.3892\/or.2015.4445","article-title":"Hispolon inhibits breast cancer cell migration by reversal of epithelial-to-mesenchymal transition via suppressing the ROS\/ERK\/Slug\/E-cadherin pathway","volume":"35","author":"Li","year":"2016","journal-title":"Oncol Rep"},{"key":"26","doi-asserted-by":"publisher","first-page":"e0154471","DOI":"10.1371\/journal.pone.0154471","article-title":"Inhibition of SK4 Potassium Channels Suppresses Cell Proliferation, Migration and the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells","volume":"11","author":"Liu","year":"2016","journal-title":"PLoS One"},{"key":"27","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s13277-012-0569-y","article-title":"Expression of TWIST1, Snail, Slug, and NF-kappaB and methylation of the TWIST1 promoter in mammary phyllodes tumor","volume":"34","author":"Cho","year":"2013","journal-title":"Tumour Biol"},{"key":"28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s12282-009-0114-z","article-title":"Phyllodes tumor of the breast: an update","volume":"17","author":"Shi","year":"2010","journal-title":"Breast Cancer"},{"key":"29","first-page":"81","article-title":"Usefulness of ultrasounds in the management of breast phyllodes tumors","volume":"33","author":"Cavallaro","year":"2012","journal-title":"G Chir"},{"key":"30","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/tbj.12333","article-title":"Malignant Phyllodes Tumor of the Breast: Treatment and Prognosis","volume":"20","author":"Skotnicki","year":"2014","journal-title":"The Breast Journal"},{"key":"31","volume-title":"WHO classification of tumours of the breast","author":"Van der Vijver","year":"2012"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.16497","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T19:05:27Z","timestamp":1589137527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.16497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,23]]},"references-count":31,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2017,5,16]]}},"alternative-id":["16497","28380418"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.16497","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,23]]}}}